EPM2AIP1 anticorps (AA 1-13)
Aperçu rapide pour EPM2AIP1 anticorps (AA 1-13) (ABIN1885601)
Antigène
Voir toutes EPM2AIP1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-13
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Synthetic peptide contain a sequence corresponding to a region within amino acids 1 and 13 of Human EPM2AIP1
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
-
Autre désignation
- EPM2AIP1
-
Sujet
-
The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy.The protein encoded by this gene binds to laforin, but its function is not known.This gene is intronless.[provided by RefSeq]
-
Poids moléculaire
- 70 kDa
-
ID gène
- 9852
-
NCBI Accession
- NP_055620, NM_014805
Antigène
-